Autoimmune Diabetes and Thyroiditis Complicating Treatment with Nivolumab

Autoimmune Diabetes and Thyroiditis Complicating Treatment with Nivolumab

Programmed cell death-1 (PD-1) ligand inhibitors have gained popularity in the treatment of advanced non-small-cell lung cancer. The immune system is regulated by stimulatory and inhibitory signaling and aims to achieve the balance between activation and inhibition. Treatment with immune checkpoint...

Full description

Bibliographic Details
Main Authors: Li Li, Awais Masood, Shahla Bari, Sahzene Yavuz, Alan B. Grosbach
Format: Article
Language:English
Published: Karger Publishers 2017-03-01
Series:Case Reports in Oncology
Subjects:
PD-1 inhibitor
Nivolumab
Autoimmune diabetes
Online Access:http://www.karger.com/Article/FullText/456540

Similar Items

Similar Items